
International Journal on Science and Technology
E-ISSN: 2229-7677
•
Impact Factor: 9.88
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 16 Issue 2
2025
Indexing Partners



















Digital Transformation: A Critical Component for CDMOs in the Pharmaceutical Industry
Author(s) | Sandeep Ramanamuni |
---|---|
Country | United States |
Abstract | This paper highlights how digital transformation is critical in developing a competitive edge and capabilities in Contract Development and Manufacturing Organizations within the pharmaceutical industry. The fact that there is increased international demand for innovative and personalized medicines puts CDMOs under pressure to provide quicker, more efficient, and more compliant services. Such research underscores how digitalization, via technologies such as ML, the IoT, digital twins, AI, and cloud-based systems, can help CDMOs streamline their operations and improve supply chain visibility and time to market. The paper further sheds light on a digital-first mindset, cybersecurity, solid data integration, and end-to-end transparency as the bases for value delivery and sustainable growth within the pharmaceutical landscape. |
Keywords | digital transformation, pharmaceutical industry, CDMO, supply chain visibility, AI, IoT, digital technologies. |
Field | Engineering |
Published In | Volume 15, Issue 4, October-December 2024 |
Published On | 2024-11-06 |
Cite This | Digital Transformation: A Critical Component for CDMOs in the Pharmaceutical Industry - Sandeep Ramanamuni - IJSAT Volume 15, Issue 4, October-December 2024. DOI 10.71097/IJSAT.v15.i4.2834 |
DOI | https://doi.org/10.71097/IJSAT.v15.i4.2834 |
Short DOI | https://doi.org/g899gg |
Share this


CrossRef DOI is assigned to each research paper published in our journal.
IJSAT DOI prefix is
10.71097/IJSAT
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
